Sign Up to like & get
recommendations!
2
Published in 2022 at "FEBS Open Bio"
DOI: 10.1002/2211-5463.13363
Abstract: Radiation and chemotherapy resistance remain some of the greatest challenges in human and veterinary cancer therapies. XRCC4, an essential molecule for nonhomologous end joining repair, is a promising target for radiosensitizers. Genetic variants and mutations…
read more here.
Keywords:
dna;
localization;
xrcc4;
xrcc4 undergoes ... See more keywords